Chevy Chase Trust Holdings, Inc. Abb Vie Inc. Transaction History
Chevy Chase Trust Holdings, Inc.
- $32.3 Billion
- Q4 2024
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 961,279 shares of ABBV stock, worth $186 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
961,279
Previous 981,596
2.07%
Holding current value
$186 Million
Previous $194 Million
11.88%
% of portfolio
0.53%
Previous 0.6%
Shares
31 transactions
Others Institutions Holding ABBV
# of Institutions
3,995Shares Held
1.29BCall Options Held
18.2MPut Options Held
13.6M-
Vanguard Group Inc Valley Forge, PA173MShares$33.4 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$15.3 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$9.99 Billion0.75% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.47 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $341B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...